EUVIMEDEUVIMED entdecken
Crossref

Cell Permeable Protein Kinase C Epsilon Peptide Inhibitor Mitigates Myocardial Ischemic- Reperfusion Injury

Lindon Young

Journal of Cardiobiology · 2024

DOI: 10.13188/2332-3671.1000026 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Cardiobiology, 2024. Verfasst von Lindon Young.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Ischemia reperfusion (I/R); Left anterior descending (LAD); Left ventricular developed pressure (LVDP); Left ventricular end-diastolic pressure (LVEDP); Left ventricular enddiastolic volume (LVEDV); Left ventricular end-systolic pressure (LVESP); Left ventricular end-systolic volume (LVESV); Maximal rate of decrease in left ventricular pressure (dP/dt min ); Maximal rate of increase in left ventricular pressure (dP/dt max )., Myocardial infarction (MI); Myocardial Ischemia Reperfusion (MIR); Myristic acid (Myr) Myr-PKCε inhibitor (YT-001); Myr-Tat-PKCε inhibitor (YT-002); Nitric Oxide (NO); Protein Kinase C (PKC); Protein Kinase C Epsilon (PKCε); Pulmonary capillary wedge pressure (PCWP); Reactive Oxygen Species (ROS); Receptor for activated C kinase 1 (RACK1) Superoxide (SO); Tetrahydrobiopterin (BH 4 ); Transactivator of transcription (Tat); Tumor Necrosis Factor Alpha (TNFa).

Zitieren

APA

Young, L. (2024). Cell Permeable Protein Kinase C Epsilon Peptide Inhibitor Mitigates Myocardial Ischemic- Reperfusion Injury. Journal of Cardiobiology. https://doi.org/10.13188/2332-3671.1000026

Vancouver

Young L. Cell Permeable Protein Kinase C Epsilon Peptide Inhibitor Mitigates Myocardial Ischemic- Reperfusion Injury. Journal of Cardiobiology. 2024. doi:10.13188/2332-3671.1000026

BibTeX
@article{Young2024,
  author = {Young, Lindon},
  title = {Cell Permeable Protein Kinase C Epsilon Peptide Inhibitor Mitigates Myocardial Ischemic- Reperfusion Injury},
  journal = {Journal of Cardiobiology},
  year = {2024},
  doi = {10.13188/2332-3671.1000026}
}
Kostenlos starten →